This week: Are the conclusion about ‘alien’ mummy, Ata correct? Where is the African DNA in the search for cures? And is it possible to bury family secrets in the age of DNA testing?
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
Billionaire philanthropist Bill Gates has donated $30 million towards incentivising the development of an Alzheimer’s diagnostic test.
Clinical trials involving probiotics are failing to report on the safety and harms of these treatments.
Melanoma is it’s treatable if caught early enough. And a new blood test might be able to help with faster and easier diagnosis. Here’s what has to happen for the test to reach clinics:
The debate about the pros and cons of genetically screening embryos is deeply entrenched. Perhaps we should let couples decide?
Researchers have for the first time, used gene-editing tools in adult monkeys to disable a gene throughout much of the liver.
Researchers have developed a gentle, contact-free method that uses sound waves to separate circulating tumour cells from blood samples quickly and efficiently enough for clinical use.
A small pilot study presented at the European Society for Human Reproduction and Embryology 2018, suggest that DNA shed from early embryos could one day provide an alternative way of genetically testing them without having to do a biopsy.
People living in England will be the first in the world to have access to DNA tests as routine care starting this fall, putting the NHS at the forefront of healthcare, as it takes a huge step towards precision medicine.
For many women diagnosed with breast cancer, genetic testing can offer important information that might guide treatment choices. A new study finds that surgeons are a key influence.
A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa’s poorest regions.
Researchers have discovered that men and women have different genetic risk factors for developing glioma.
Cancer Research UK Cambridge Institute is pushing for the use of genetic testing to transform treatment of breast cancer with the Personalised Breast Cancer Programme.
The California State Legislature has approved a budget including $2 million for a pilot project to fund clinical whole genome sequencing as a first line diagnostic test.